Fiztasovimab
Product Specifications
CAS Number
2467411-25-0
Target
Virus Protease
Related Pathways
Microbiology/Virology
Bioactivity
Fiztasovimab (NPC-21; EV2038), a fully human IgG1? monoclonal antibody (mAb), targets human cytomegalovirus (hCMV) . It exerts its neutralizing activity through binding to the antigenic domain 1 of glycoprotein B on the hCMV envelope, effectively inhibiting cell-to-cell transmission of hCMV [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1052998-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details 
MBS1052998-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details 
MBS1052998-03 0.02 mg (Yeast)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details MBS1052998-04 0.1 mg (Yeast)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details MBS1052998-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details 
MBS1052998-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O81 Transcriptional repressor NrdR (nrdR)
Ask
View Details